Pub Date : 2024-08-05DOI: 10.1007/s44254-024-00066-2
Yuanbo Ni, Min Yu, Cunming Liu
Sleep is an essential physiological process that promotes physical recovery and helps consolidate learning and memory. Common manifestations of sleep disturbances include insomnia, hypersomnia, circadian rhythm disorders, and parasomnias, all of which impair cognitive function, particularly in the elderly. Cognitive impairment is a significant factor that threatens the quality of life in the elderly, and there is currently no effective treatment for conditions such as dementia. The relationship between sleep and cognition is complex. Studies have shown that sleep disorders adversely affect cognitive function and increase the incidence of cognitive decline. This article focuses on sleep disturbances and their effects on the cognition of the elderly by reviewing research conducted over the past 20 years and describing potential mechanisms. Additionally, we explore the relationship between sleep and cognition during the perioperative period, aiming to identify strategies for optimizing perioperative sleep quality. We believe this review provides a deeper understanding of the association between sleep and cognition and offers a new perspective for perioperative management.
{"title":"Sleep disturbance and cognition in the elderly: a narrative review","authors":"Yuanbo Ni, Min Yu, Cunming Liu","doi":"10.1007/s44254-024-00066-2","DOIUrl":"10.1007/s44254-024-00066-2","url":null,"abstract":"<div><p>Sleep is an essential physiological process that promotes physical recovery and helps consolidate learning and memory. Common manifestations of sleep disturbances include insomnia, hypersomnia, circadian rhythm disorders, and parasomnias, all of which impair cognitive function, particularly in the elderly. Cognitive impairment is a significant factor that threatens the quality of life in the elderly, and there is currently no effective treatment for conditions such as dementia. The relationship between sleep and cognition is complex. Studies have shown that sleep disorders adversely affect cognitive function and increase the incidence of cognitive decline. This article focuses on sleep disturbances and their effects on the cognition of the elderly by reviewing research conducted over the past 20 years and describing potential mechanisms. Additionally, we explore the relationship between sleep and cognition during the perioperative period, aiming to identify strategies for optimizing perioperative sleep quality. We believe this review provides a deeper understanding of the association between sleep and cognition and offers a new perspective for perioperative management.</p></div>","PeriodicalId":100082,"journal":{"name":"Anesthesiology and Perioperative Science","volume":"2 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s44254-024-00066-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142409873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Low back pain (LBP) is a common and recurring public health problem that affects sufferers both physically and mentally and warrants further research. A succession of studies have suggested a plausible role for inflammatory cytokines in the pathogenesis of LBP. To date, there is no conclusive mechanism explaining how inflammatory cytokines affects LBP.
Methods
A bidirectional two-sample Mendelian randomization (MR) investigation was undertaken in two stages. The initial phase encompassed 41 inflammatory cytokines as the exposure, with LBP as the outcome, and the subsequent phase adopted the inverse approach. A total of 41 blood inflammatory cytokines were extracted from the genome-wide association study meta-analysis database, encompassing 8,293 individuals. Data pertaining to LBP were acquired from the Finnish biobank. Primary findings were computed using inverse-variance weighting (IVW), while sensitivity analyses accounting for pleiotropy and invalid instruments were conducted utilizing the weighted-median estimator, MR-Egger, and MR Pleiotropy RESidual Sum and Outlier.
Results
Our results suggest that higher levels of Macrophage migration inhibitory factor (MIF) as well as lower levels of C-C motif chemokine ligand 3 (CCL3) are associated with an increased risk of LBP (odds ratio [OR] = 1.134, 95% confidence interval [CI ]= 1.032–1.245, P = 0.009; OR = 0.887, 95% CI = 0.803–0.980, P = 0.018). Moreover, there was no heterogeneity and horizontal pleiotropy observed in the sensitivity analysis. In contrast, in studies of the effect of LBP on inflammatory cytokines, genetically determined LBP had no causal effect on 41 inflammatory cytokines (IVW P > 0.05).
Conclusions
Our study confirms that the levels of circulating MIF and CCL3 may be regarded as valuable circulating inflammatory biomarkers for the management of LBP in clinical practice and as potential molecules for future mechanistic investigation and drug target identification.
目的腰背痛(LBP)是一种常见的、反复发作的公共健康问题,对患者的身心都有影响,值得进一步研究。一系列研究表明,炎性细胞因子在腰背痛的发病机制中扮演着可信的角色。迄今为止,炎性细胞因子如何影响枸杞多糖症尚无定论。第一阶段以 41 种炎症细胞因子为暴露因子,以枸杞痛为结果,随后的阶段采用反向方法。研究人员从全基因组关联研究荟萃分析数据库中提取了 41 种血液炎症细胞因子,共涉及 8293 人。有关枸杞多糖的数据来自芬兰生物库。利用逆方差加权法(IVW)计算了主要研究结果,并利用加权中值估计法、MR-Egger 和 MR Pleiotropy RESidual Sum and Outlier 进行了多义性和无效工具的敏感性分析。结果我们的研究结果表明,较高水平的巨噬细胞迁移抑制因子(MIF)和较低水平的C-C motif趋化因子配体3(CCL3)与枸杞痛风险的增加有关(比值比[OR] = 1.134,95% 置信区间[CI ]= 1.032-1.245,P = 0.009;OR = 0.887,95% CI = 0.803-0.980,P = 0.018)。此外,在敏感性分析中没有观察到异质性和水平多向性。相反,在枸杞多糖对炎症细胞因子影响的研究中,基因决定的枸杞多糖对 41 种炎症细胞因子没有因果效应(IVW P > 0.05)。结论我们的研究证实,循环 MIF 和 CCL3 的水平可被视为临床实践中治疗枸杞多糖的有价值的循环炎症生物标志物,也是未来机理研究和药物靶点鉴定的潜在分子。
{"title":"Exploring causal correlations between blood inflammatory cytokines and low back pain: a Mendelian randomization","authors":"Hao Tian, Jianxin Cheng, Xiaoshuai Zhao, Zhongyuan Xia","doi":"10.1007/s44254-024-00063-5","DOIUrl":"10.1007/s44254-024-00063-5","url":null,"abstract":"<div><h3>Purpose</h3><p>Low back pain (LBP) is a common and recurring public health problem that affects sufferers both physically and mentally and warrants further research. A succession of studies have suggested a plausible role for inflammatory cytokines in the pathogenesis of LBP. To date, there is no conclusive mechanism explaining how inflammatory cytokines affects LBP.</p><h3>Methods</h3><p>A bidirectional two-sample Mendelian randomization (MR) investigation was undertaken in two stages. The initial phase encompassed 41 inflammatory cytokines as the exposure, with LBP as the outcome, and the subsequent phase adopted the inverse approach. A total of 41 blood inflammatory cytokines were extracted from the genome-wide association study meta-analysis database, encompassing 8,293 individuals. Data pertaining to LBP were acquired from the Finnish biobank. Primary findings were computed using inverse-variance weighting (IVW), while sensitivity analyses accounting for pleiotropy and invalid instruments were conducted utilizing the weighted-median estimator, MR-Egger, and MR Pleiotropy RESidual Sum and Outlier.</p><h3>Results</h3><p>Our results suggest that higher levels of Macrophage migration inhibitory factor (MIF) as well as lower levels of C-C motif chemokine ligand 3 (CCL3) are associated with an increased risk of LBP (odds ratio [OR] = 1.134, 95% confidence interval [CI ]= 1.032–1.245, <i>P</i> = 0.009; OR = 0.887, 95% CI = 0.803–0.980, <i>P</i> = 0.018). Moreover, there was no heterogeneity and horizontal pleiotropy observed in the sensitivity analysis. In contrast, in studies of the effect of LBP on inflammatory cytokines, genetically determined LBP had no causal effect on 41 inflammatory cytokines (IVW <i>P</i> > 0.05).</p><h3>Conclusions</h3><p>Our study confirms that the levels of circulating MIF and CCL3 may be regarded as valuable circulating inflammatory biomarkers for the management of LBP in clinical practice and as potential molecules for future mechanistic investigation and drug target identification.\u0000</p></div>","PeriodicalId":100082,"journal":{"name":"Anesthesiology and Perioperative Science","volume":"2 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s44254-024-00063-5.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142409138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-10DOI: 10.1007/s44254-024-00061-7
Chiara Angeletti, Francesca Angelucci, Maria P. Bernardi, Laura Cedrone, Michela Di Carlo, Paolo Scimia, Guido Torresini, Alessandra Ciccozzi, Federica Venturoni
{"title":"A personalized plan case for managing myasthenia gravis involves using thoracic fascial plane blocks and dexmedetomidine/propofol infusion in breast surgery","authors":"Chiara Angeletti, Francesca Angelucci, Maria P. Bernardi, Laura Cedrone, Michela Di Carlo, Paolo Scimia, Guido Torresini, Alessandra Ciccozzi, Federica Venturoni","doi":"10.1007/s44254-024-00061-7","DOIUrl":"10.1007/s44254-024-00061-7","url":null,"abstract":"","PeriodicalId":100082,"journal":{"name":"Anesthesiology and Perioperative Science","volume":"2 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s44254-024-00061-7.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141661870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-04DOI: 10.1007/s44254-024-00060-8
Jason Timothy Pan, Kay Choong See
High-flow nasal cannula (HFNC) has been widely promoted during the COVID-19 pandemic to circumvent invasive mechanical ventilation. While there are several reported benefits, randomized trials demonstrate inconsistent variable success. We hypothesize that this is due to variable stopping criteria. This systematic review’s purpose is to review these criteria and investigate any associations with HFNC outcomes. We searched PubMed and EMBASE for all English-language randomized controlled trials (RCTs) published from January 1, 2007, to December 31, 2022, focusing on respiratory rate as a threshold for escalation of respiratory support. Subgroup analysis was conducted based on trial failure criteria, and intubation and mortality benefits were studied. Fisher’s exact test was performed following a 5% level of significance. Of the 22 RCTs included, 4 (18.2%) reported significant intubation benefits and 1 (0.05%) reported significant mortality benefit. The presence of objective failure criteria with a prespecified high respiratory rate threshold (35 breaths per minute or higher) had a significant effect on intubation rate reduction (P = 0.02). However, this result might be limited by the heterogeneity of the included studies. Further RCTs are required to confirm this conclusion. Given that a high respiratory rate threshold was associated with a reduction of intubation without increasing mortality, we hypothesize that among patients receiving HFNC who were eventually not intubated, the avoidance of intubation led to better clinical outcomes, while among eventually intubated patients, delays led to poorer outcomes.
{"title":"Criteria for stopping high-flow nasal oxygen for acute hypoxemic respiratory failure: a systematic review of randomized controlled trials","authors":"Jason Timothy Pan, Kay Choong See","doi":"10.1007/s44254-024-00060-8","DOIUrl":"10.1007/s44254-024-00060-8","url":null,"abstract":"<div><p>High-flow nasal cannula (HFNC) has been widely promoted during the COVID-19 pandemic to circumvent invasive mechanical ventilation. While there are several reported benefits, randomized trials demonstrate inconsistent variable success. We hypothesize that this is due to variable stopping criteria. This systematic review’s purpose is to review these criteria and investigate any associations with HFNC outcomes. We searched PubMed and EMBASE for all English-language randomized controlled trials (RCTs) published from January 1, 2007, to December 31, 2022, focusing on respiratory rate as a threshold for escalation of respiratory support. Subgroup analysis was conducted based on trial failure criteria, and intubation and mortality benefits were studied. Fisher’s exact test was performed following a 5% level of significance. Of the 22 RCTs included, 4 (18.2%) reported significant intubation benefits and 1 (0.05%) reported significant mortality benefit. The presence of objective failure criteria with a prespecified high respiratory rate threshold (35 breaths per minute or higher) had a significant effect on intubation rate reduction (<i>P</i> = 0.02). However, this result might be limited by the heterogeneity of the included studies. Further RCTs are required to confirm this conclusion. Given that a high respiratory rate threshold was associated with a reduction of intubation without increasing mortality, we hypothesize that among patients receiving HFNC who were eventually not intubated, the avoidance of intubation led to better clinical outcomes, while among eventually intubated patients, delays led to poorer outcomes.</p></div>","PeriodicalId":100082,"journal":{"name":"Anesthesiology and Perioperative Science","volume":"2 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s44254-024-00060-8.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141679555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-27DOI: 10.1007/s44254-024-00062-6
Xiaojuan Jiang, Qinqin Yin, Xiaoqian Deng, Wensheng Zhang, Weiyi Zhang, Jin Liu
{"title":"Advance of a new etomidate analogue — methoxyethyl etomidate hydrochloride (ET-26) for anesthesia induction in surgical patients","authors":"Xiaojuan Jiang, Qinqin Yin, Xiaoqian Deng, Wensheng Zhang, Weiyi Zhang, Jin Liu","doi":"10.1007/s44254-024-00062-6","DOIUrl":"10.1007/s44254-024-00062-6","url":null,"abstract":"","PeriodicalId":100082,"journal":{"name":"Anesthesiology and Perioperative Science","volume":"2 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s44254-024-00062-6.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142414299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-23DOI: 10.1007/s44254-024-00052-8
Le Xu, Yanhong Li, Hong Zheng, Rurong Wang
With advancements in sedation techniques,painless gastrointestinal endoscopy has expanded from a diagnostic role to surgeries. This study aims to explore strategies for enhancing patient satisfaction, improving safety, and reducing complications. Tailoring preoperative assessments beyond American Society of Anesthesiologists classification is crucial, especially for the elderly and pediatric populations. Integration of scales and point-of-care testing (POCT) provides a precise baseline evaluations. Optimizing anesthetic strategies through improved drug selection and enhanced perioperative monitoring follows accurate patient evaluations. While post-procedural follow-up is essential, existing studies in this area are limited. This article outlines current painless gastrointestinal endoscopy technology, emphasizing POCT establishment, personalized monitoring, and optimized anesthesia strategies for a positive impact on patient outcomes.
{"title":"Optimizing perioperative anesthesia strategies for safety and high-quality during painless gastrointestinal endoscopy diagnosis and treatment","authors":"Le Xu, Yanhong Li, Hong Zheng, Rurong Wang","doi":"10.1007/s44254-024-00052-8","DOIUrl":"10.1007/s44254-024-00052-8","url":null,"abstract":"<div><p>With advancements in sedation techniques,painless gastrointestinal endoscopy has expanded from a diagnostic role to surgeries. This study aims to explore strategies for enhancing patient satisfaction, improving safety, and reducing complications. Tailoring preoperative assessments beyond American Society of Anesthesiologists classification is crucial, especially for the elderly and pediatric populations. Integration of scales and point-of-care testing (POCT) provides a precise baseline evaluations. Optimizing anesthetic strategies through improved drug selection and enhanced perioperative monitoring follows accurate patient evaluations. While post-procedural follow-up is essential, existing studies in this area are limited. This article outlines current painless gastrointestinal endoscopy technology, emphasizing POCT establishment, personalized monitoring, and optimized anesthesia strategies for a positive impact on patient outcomes.</p></div>","PeriodicalId":100082,"journal":{"name":"Anesthesiology and Perioperative Science","volume":"2 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s44254-024-00052-8.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140670195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-17DOI: 10.1007/s44254-024-00059-1
Yun Hao Leong, You Liang Khoo, Hairil Rizal Abdullah, Yuhe Ke
Purpose
Ventilator care bundles are effective in the prevention of ventilator-associated pneumonia (VAP). However, the compliance of these bundles in intensive care units (ICUs) remains poorly studied. This study investigates the Medical Information Mart for Intensive Care (MIMIC)-IV cohort’s compliance with the Institute for Healthcare Improvement (IHI) bundle and its resulting association with VAP incidence.
Methods
This is a retrospective cohort study of the MIMIC-IV database. Patients with > 48 h of invasive mechanical ventilation (IMV) were included. Diagnosis of VAP was identified with the International Classification of Diseases (ICD)-9 and ICD-10 codes. Compliance rates to the IHI bundle were extracted. The association of the IHI bundle and its individual interventions with VAP incidence was analyzed with univariate and multivariate analysis.
Results
8270 patients were included, of which 1328 (16.1%) had VAP. 25 patients (0.3%) had full compliance to the IHI bundle. 137 patients (1.7%) received no interventions from the bundle. Gastroprophylaxis had the lowest (2.1%) while head elevation had the highest (89.3%) compliance rates. In patients receiving the IHI bundle, each additional intervention was associated with lower VAP incidence (OR [odds ratio] = 0.906, 95% CI [confidence interval] 0.847–0.969). Appropriate sedation levels (OR = 0.765, 95% CI 0.661–0.885) and the use of heat and moisture exchanger (HME) filters (OR = 0.862, 95% CI 0.745–0.998) were individually associated with reduced VAP incidence, while active humidification was individually associated with increased VAP incidence (OR = 1.139, 95% CI 1.001–1.296).
Conclusion
The use of the IHI bundle was associated with a lower incidence of VAP, but compliance with the bundle was poor. Appropriate sedation and HME filters were individually associated with reduced VAP incidence. Better compliance with the IHI bundle may reduce VAP rates in mechanically ventilated patients.